Researchers Seek to Develop Genetically Engineered Brain Cancer Treatment
Scientists at Purdue University are trying to develop a new treatment for glioblastoma tumors. Glioblastoma is a type of cancer that originates in the spinal cord and/or brain. This cancer is fatal, with a median time of survival of 14 months. Conventional treatments for other cancers, including immunotherapy and chemotherapy, are ineffective on this particular cancer. These treatments work by blood cells being taken from a patient then reintroduced back into their bodies after genetic engineering to fight cancer cells. This study was led by associate professor Sandro Matosevic of Purdue’s department of industrial and molecular pharmaceutics. The study’s objective…